How much revenue did Brainsway generate this year?
Brainsway has achieved a revenue of 148.95 M USD this year.
Brainsway Revenue 2024
Brainsway Revenue
148.95 M USD
Ticker
BWAY.TA
ISIN
IL0011007189
WKN
A0NDVW
In 2024, Brainsway's sales reached 148.95 M USD, a 368.62% difference from the 31.79 M USD sales recorded in the previous year.
The Brainsway Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 150.32 | 15,62 |
| 2025e | 176.02 | 13,34 |
| 2024e | 148.95 | 15,76 |
| 2023 | 31.79 | 73,86 |
| 2022 | 27.18 | 73,77 |
| 2021 | 29.66 | 77,75 |
| 2020 | 22.06 | 77,06 |
| 2019 | 23.1 | 77,79 |
| 2018 | 16.4 | 78,11 |
| 2017 | 11.15 | 76,68 |
| 2016 | 11.52 | 78,99 |
| 2015 | 6.8 | 78,38 |
| 2014 | 3.38 | 80,47 |
| 2013 | 1.19 | 83,19 |
| 2012 | 0.35 | 88,57 |
| 2011 | 0.27 | 88,89 |
| 2010 | 0.09 | 88,89 |
| 2009 | - | - |
| 2008 | - | - |
| 2007 | - | - |
| 2006 | - | - |
Brainsway Revenue, EBIT, Net Income IL0011007189 · A0NDVW
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Brainsway, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Brainsway from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Brainsway’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Brainsway. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Brainsway’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Brainsway’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Brainsway’s growth potential.
Brainsway Revenue, Profit, and EBIT History
| Date | Brainsway Revenue | Brainsway EBIT | Brainsway Net Income |
|---|---|---|---|
| 2026e | 150.32 M undefined | 74.17 M undefined | -41.33 M undefined |
| 2025e | 176.02 M undefined | 18.19 M undefined | 14.48 M undefined |
| 2024e | 148.95 M undefined | 4.74 M undefined | 1.89 M undefined |
| 2023 | 31.79 M undefined | -4.96 M undefined | -4.2 M undefined |
| 2022 | 27.18 M undefined | -12.68 M undefined | -13.35 M undefined |
| 2021 | 29.66 M undefined | -5 M undefined | -6.46 M undefined |
| 2020 | 22.06 M undefined | -4.83 M undefined | -5.39 M undefined |
| 2019 | 23.1 M undefined | -8.48 M undefined | -10.33 M undefined |
| 2018 | 16.4 M undefined | -5.11 M undefined | -6.48 M undefined |
| 2017 | 11.15 M undefined | -6.61 M undefined | -7.05 M undefined |
| 2016 | 11.52 M undefined | -2.07 M undefined | -2.4 M undefined |
| 2015 | 6.8 M undefined | -4.51 M undefined | -4.09 M undefined |
| 2014 | 3.38 M undefined | -7.28 M undefined | -6.55 M undefined |
| 2013 | 1.19 M undefined | -4.28 M undefined | -7.13 M undefined |
| 2012 | 350,000 undefined | -5.51 M undefined | -5.74 M undefined |
| 2011 | 270,000 undefined | -6.99 M undefined | -6.82 M undefined |
| 2010 | 90,000 undefined | -5.3 M undefined | -1.14 M undefined |
| 2009 | 0 undefined | -2.73 M undefined | -7.98 M undefined |
| 2008 | 0 undefined | -1.56 M undefined | -2.26 M undefined |
| 2007 | 0 undefined | -1.23 M undefined | -2.39 M undefined |
| 2006 | 0 undefined | -300,000 undefined | -300,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2006 | 0 USD | -300,000 USD | -300,000 USD |
| 2007 | 0 USD | -1.23 M USD | -2.39 M USD |
| 2008 | 0 USD | -1.56 M USD | -2.26 M USD |
| 2009 | 0 USD | -2.73 M USD | -7.98 M USD |
| 2010 | 90,000 USD | -5.3 M USD | -1.14 M USD |
| 2011 | 270,000 USD | -6.99 M USD | -6.82 M USD |
| 2012 | 350,000 USD | -5.51 M USD | -5.74 M USD |
| 2013 | 1.19 M USD | -4.28 M USD | -7.13 M USD |
| 2014 | 3.38 M USD | -7.28 M USD | -6.55 M USD |
| 2015 | 6.8 M USD | -4.51 M USD | -4.09 M USD |
| 2016 | 11.52 M USD | -2.07 M USD | -2.4 M USD |
| 2017 | 11.15 M USD | -6.61 M USD | -7.05 M USD |
| 2018 | 16.4 M USD | -5.11 M USD | -6.48 M USD |
| 2019 | 23.1 M USD | -8.48 M USD | -10.33 M USD |
| 2020 | 22.06 M USD | -4.83 M USD | -5.39 M USD |
| 2021 | 29.66 M USD | -5 M USD | -6.46 M USD |
| 2022 | 27.18 M USD | -12.68 M USD | -13.35 M USD |
| 2023 | 31.79 M USD | -4.96 M USD | -4.2 M USD |
| 2024e | 148.95 M USD | 4.74 M USD | 1.89 M USD |
| 2025e | 176.02 M USD | 18.19 M USD | 14.48 M USD |
| 2026e | 150.32 M USD | 74.17 M USD | -41.33 M USD |
Brainsway stock margins IL0011007189 · A0NDVW
The Brainsway margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Brainsway. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Brainsway.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Brainsway's sales revenue. A higher gross margin percentage indicates that the Brainsway retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Brainsway's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Brainsway's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Brainsway's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Brainsway. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Brainsway's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Brainsway Margin History
| Brainsway Gross margin | Brainsway Profit margin | Brainsway EBIT margin | Brainsway Profit margin |
|---|---|---|---|
| 2026e | 73.86 % | 49.34 % | -27.49 % |
| 2025e | 73.86 % | 10.34 % | 8.23 % |
| 2024e | 73.86 % | 3.18 % | 1.27 % |
| 2023 | 73.86 % | -15.6 % | -13.2 % |
| 2022 | 73.77 % | -46.65 % | -49.12 % |
| 2021 | 77.75 % | -16.86 % | -21.78 % |
| 2020 | 77.06 % | -21.89 % | -24.43 % |
| 2019 | 77.79 % | -36.71 % | -44.72 % |
| 2018 | 78.11 % | -31.16 % | -39.51 % |
| 2017 | 76.68 % | -59.28 % | -63.23 % |
| 2016 | 78.99 % | -17.97 % | -20.83 % |
| 2015 | 78.38 % | -66.32 % | -60.15 % |
| 2014 | 80.47 % | -215.38 % | -193.79 % |
| 2013 | 83.19 % | -359.66 % | -599.16 % |
| 2012 | 88.57 % | -1,574.29 % | -1,640 % |
| 2011 | 88.89 % | -2,588.89 % | -2,525.93 % |
| 2010 | 88.89 % | -5,888.89 % | -1,266.67 % |
| 2009 | 73.86 % | 0 % | 0 % |
| 2008 | 73.86 % | 0 % | 0 % |
| 2007 | 73.86 % | 0 % | 0 % |
| 2006 | 73.86 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2006 | 73.86 % | 0 % | 0 % |
| 2007 | 73.86 % | 0 % | 0 % |
| 2008 | 73.86 % | 0 % | 0 % |
| 2009 | 73.86 % | 0 % | 0 % |
| 2010 | 88.89 % | -5,888.89 % | -1,266.67 % |
| 2011 | 88.89 % | -2,588.89 % | -2,525.93 % |
| 2012 | 88.57 % | -1,574.29 % | -1,640 % |
| 2013 | 83.19 % | -359.66 % | -599.16 % |
| 2014 | 80.47 % | -215.38 % | -193.79 % |
| 2015 | 78.38 % | -66.32 % | -60.15 % |
| 2016 | 78.99 % | -17.97 % | -20.83 % |
| 2017 | 76.68 % | -59.28 % | -63.23 % |
| 2018 | 78.11 % | -31.16 % | -39.51 % |
| 2019 | 77.79 % | -36.71 % | -44.72 % |
| 2020 | 77.06 % | -21.89 % | -24.43 % |
| 2021 | 77.75 % | -16.86 % | -21.78 % |
| 2022 | 73.77 % | -46.65 % | -49.12 % |
| 2023 | 73.86 % | -15.6 % | -13.2 % |
| 2024e | 73.86 % | 3.18 % | 1.27 % |
| 2025e | 73.86 % | 10.34 % | 8.23 % |
| 2026e | 73.86 % | 49.34 % | -27.49 % |
Brainsway Aktienanalyse
What does Brainsway do?
Brainsway Ltd is a leading provider of non-invasive brain stimulation solutions based in Jerusalem, Israel. The company was founded in 2003 and has since become a major player in the field of neurological disorders. Brainsway's business model includes the development, production, and marketing of innovative brain stimulation solutions. The company's products are based on transcranial magnetic stimulation (TMS), a proven technology for treating neurological disorders. TMS involves generating brain stimulation through a non-invasive method, using gentle magnetic pulses directed at the targeted area of the brain to specifically influence brain activity. The company is divided into three business areas: psychiatry, neurology, and rehabilitation. The psychiatry area includes the treatment of disorders such as depression, obsessive-compulsive disorder, addiction, and schizophrenia. The neurology area, on the other hand, focuses on disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. The rehabilitation area is used for anatomical rehabilitation and stroke rehabilitation and is the newest product of Brainsway. Each area includes a variety of products tailored to the individual needs of users. One of Brainsway's most well-known products is the Deep TMS Stimulator, which was specifically developed for the treatment of depression. The Deep TMS therapy has been clinically tested and identified as an effective method for treating depression, obsessive-compulsive disorder, and ADHD. The device has already been marketed in over twenty countries. Brainsway is also a leader in the treatment of Parkinson's disease with TMS. Clinical studies have shown that the application of Brainsway TMS in Parkinson's patients reduces symptoms by almost 50%. The benefits of TMS in Parkinson's include improved motor function, increased quality of life, and a reduction in the frequency of falls. The company has established collaborations with major pharmaceutical companies and research institutions. Brainsway works closely with scientific institutions to continuously develop and improve therapies and products. Brainsway Ltd is an innovative company that is a leader in the field of non-invasive brain stimulation. Brainsway's products have proven to be effective in treating a variety of disorders, and the company has a promising future in researching and developing new therapies. Brainsway ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Brainsway's Sales Figures
The sales figures of Brainsway originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Brainsway’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Brainsway's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Brainsway’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Brainsway Stock
How much was the turnover of the company Brainsway compared to the previous year?
The revenue of Brainsway has increased by 368.62% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Brainsway?
The revenue of Brainsway is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Brainsway measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Brainsway so important for investors?
The revenue of Brainsway is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Brainsway pay?
Over the past 12 months, Brainsway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Brainsway is expected to pay a dividend of 0 USD.
What is the dividend yield of Brainsway?
The current dividend yield of Brainsway is .
When does Brainsway pay dividends?
Brainsway pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Brainsway?
Brainsway paid dividends every year for the past 0 years.
What is the dividend of Brainsway?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Brainsway located?
Brainsway is assigned to the 'Health' sector.
Wann musste ich die Aktien von Brainsway kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Brainsway from 6/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/24/2024.
When did Brainsway pay the last dividend?
The last dividend was paid out on 6/24/2024.
What was the dividend of Brainsway in the year 2023?
In the year 2023, Brainsway distributed 0 USD as dividends.
In which currency does Brainsway pay out the dividend?
The dividends of Brainsway are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Brainsway
Our stock analysis for Brainsway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Brainsway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
